David Luci
President and CEO at Acurx Pharmaceuticals, Inc. NASDAQ: ACXP; Acurx Pharmaceuticals is a publicly held, clinical stage biopharmaceutical company.
- Role
- Chairman at Digital Prime Technologies
- Location
- Staten Island, NY, US
- LinkedIn followers
- 500 followers
About David Luci
I am the co-founder, President, and CEO of Acurx Pharmaceuticals, Inc.(NASDAQ: ACXP)…
Experience
Chairman
Mar 2019 — Present · New York, NY, US
Digital Prime Technologies enables its clients to quickly and easily deploy a full suite of prime brokerage solutions. While the digital assets sector is complicated and evolving rapidly, Digital Prime Technologies’ product suite allows traditional Wall Street firms, as well as other clients, to enter the digital asset space with a robust and fully customizable prime services suite suited to their business and compliance needs.
Education
Albany Law School
JD, Law
1991 — 1994
Bucknell University
BSBA, Accounting and Business
1984 — 1988
Skills
- Risk Management
- Mergers
- Contract Negotiation
- Start-Ups
- Due Diligence
- Strategic Planning
- Pharmaceutical Industry
- Public Companies
- Business Strategy
- Biotechnology
- Corporate Development
- Structured Finance
- Intellectual Property
- Negotiation
- Emerging Markets
- Product Development
- Corporate Law
- M&a Experience
- Ipo
- Strategy
- Private Placements
- Structuring
- Pharmaceuticals
- Valuation
- Venture Financing
- Corporate Finance
- Mergers & Acquisitions
- Investor Relations
- Entrepreneurship
- Strategy Development
- Budgeting
- Project Finance
- Securities Law
- Strategic Partnerships
- Financial Analysis
- Joint Ventures
- Securities Regulation
- Venture Capital
- Securities
- Restructuring
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.